Wes Sisson
2Patents
1h-index
6Co-inventors
30Inventor score
Filing activity: Mar 14, 2014 → Sep 16, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9789170B2 | Arginine deiminase with reduced cross-reactivity toward ADI-PEG 20 antibodies for cancer treatment | Emerging Cross-Sectional Technologies | 4 | Active |
| US11235037B2 | Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatment | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.